Mitral valve disease prevalence is on the rise worldwide, affecting an estimated 2% of the general population. Novel transcatheter mitral valve replacement technologies are being developed and may provide a viable and safe option in patients who are deemed otherwise not suitable candidates for conventional mitral valve surgery. This article reviews these devices and describes trials of first in-human use.
View Article and Find Full Text PDFCurr Opin Cardiol
March 2013
Purpose Of Review: Transcatheter mitral valve-in-valve (MVIV) implantation is an emerging technique for reoperative mitral valve replacement in high-risk patients. Clear guidelines on the use of transcatheter MVIV implantation are yet to be determined. In this review, we report our own experience as well as the recent available literature on this procedure.
View Article and Find Full Text PDF